Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermAssetCharges,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,regularMarketChangePercent,regularMarketDayRange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,industry,address2
t0,EPLYF,34628000000.0,44192200,,,1344000000,3274000000,529000000,4655000000,6128000000,1473000000,1473000000,,-8000000,,,,844000000,18141000000,16668000000,12013000000,-129000000,,500000000,529000000,1722000000.0,12828000000.0,31169000000.0,45981000000.0,12098000000.0,80424000000.0,3888000000.0,4107000000.0,31159000000.0,5017000000.0,9631000000.0,-1894000000.0,1000000.0,21511000000.0,26002000000.0,806000000.0,796000000.0,9437000000.0,49834000000.0,9799000000.0,1460000000.0,18348000000.0,150000000.0,4408000000.0,1601000000.0,,0,23832000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,16.3,1629395054,0.0,16.3,16.3,16.3,55,16.3,finmb_13104144,Other OTC,"EPS Holdings, Inc.",JPY,15,0,7.1849995,0.78826106,9.115 - 16.3,0.0,0.0,9.115,16.3,20.0,29.744526,1.2269939,REGULAR,us_market,EPS HOLDINGS INC,0,False,False,2,0.0,16.3 - 16.3,0.548,1050.582,16.083055,0.21694374,0.013488963,13.085471,3.214528,0.24565627,766357504,0.015515208,15,America/New_York,EDT,-14400000,0.79,,,16.3,9.11,16.08,13.09,15,,44.19M,,5.73M,83.23%,13.01%,,,,,,0.19,1.16%,20.00,122.70%,,32.64%,,"Sep 28, 2021",100:1,"Mar 26, 2014","Sep 29, 2020","Jun 29, 2021",4.27%,9.28%,5.68%,6.37%,71.74B,1623.13,22.40%,20.63B,9.04B,3.06B,0.55,230.60%,22.97B,519.79,10.9B,22.14,1.92,1050.58,,,Value,162-0821,Healthcare,6716,"EPS Holdings, Inc., through its subsidiaries, provides outsourced solutions to customers in the healthcare industry. It provides contract research organization (CRO) services and management of CRO segment activities; site management organization services; contract MR services, DI, and other call center services related BPO services, as well as medical device support services; contract sales solutions, including recruitment, training, and development of MRs (permanent, contract staffing, and temp to-perm), as well as medical communications programs and training; and promotion and BPO services for healthcare companies. The company also engages in clinical research related business; provision of IT services for pharmaceutical and medical settings; the import and export of products for non-clinical research, and provision of distribution services; research and development, manufacture, and sale of pharmaceuticals and medical devices; and provision of human studies (functionality and safety evaluations), basic research and animal studies, food composition analysis, research on functional substances, and other research and analysis services, as well as consulting in support of functional food development and other activities. In addition, it engages in trading, investment, and other businesses; shared services; rental and sale of advanced medical and other devices; and sale of clinical trial and other types of life and non-life insurance. The company serves pharmaceutical companies, medical device manufacturers, pharmaceutical development ventures, medical institutions, and universities and research institution in Japan and Asia. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan. As of July 8, 2021, EPS Holdings, Inc. operates as a subsidiary of Y&G Limited.",Tokyo,81 3 5684 7873,Japan,http://www.eps-holdings.co.jp,86400,Kagurazaka AK Building,Diagnostics & Research,6th Floor 1-8 Tsukudo-cho Shinjuku-ku
t-1,EPLYF,39553000000.0,44192200,,,2619000000,2949000000,1613000000,4298000000,6656000000,2358000000,2358000000,,-5000000,,,,984000000,18772000000,16414000000,12116000000,261000000,,1635000000,1613000000,1423000000.0,12828000000.0,21791000000.0,46430000000.0,10830000000.0,71170000000.0,3888000000.0,3226000000.0,31183000000.0,3181000000.0,5454000000.0,-1469000000.0,1000000.0,20124000000.0,17760000000.0,159000000.0,1213000000.0,8359000000.0,45361000000.0,10572000000.0,1179000000.0,17449000000.0,850000000.0,3383000000.0,1228000000.0,,0,27601000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,16.3,1629395054,0.0,16.3,16.3,16.3,55,16.3,finmb_13104144,Other OTC,"EPS Holdings, Inc.",JPY,15,0,7.1849995,0.78826106,9.115 - 16.3,0.0,0.0,9.115,16.3,20.0,29.744526,1.2269939,REGULAR,us_market,EPS HOLDINGS INC,0,False,False,2,0.0,16.3 - 16.3,0.548,1050.582,16.083055,0.21694374,0.013488963,13.085471,3.214528,0.24565627,766357504,0.015515208,15,America/New_York,EDT,-14400000,0.79,,,16.3,9.11,16.08,13.09,15,,44.19M,,5.73M,83.23%,13.01%,,,,,,0.19,1.16%,20.00,122.70%,,32.64%,,"Sep 28, 2021",100:1,"Mar 26, 2014","Sep 29, 2020","Jun 29, 2021",4.27%,9.28%,5.68%,6.37%,71.74B,1623.13,22.40%,20.63B,9.04B,3.06B,0.55,230.60%,22.97B,519.79,10.9B,22.14,1.92,1050.58,,,Value,162-0821,Healthcare,6716,"EPS Holdings, Inc., through its subsidiaries, provides outsourced solutions to customers in the healthcare industry. It provides contract research organization (CRO) services and management of CRO segment activities; site management organization services; contract MR services, DI, and other call center services related BPO services, as well as medical device support services; contract sales solutions, including recruitment, training, and development of MRs (permanent, contract staffing, and temp to-perm), as well as medical communications programs and training; and promotion and BPO services for healthcare companies. The company also engages in clinical research related business; provision of IT services for pharmaceutical and medical settings; the import and export of products for non-clinical research, and provision of distribution services; research and development, manufacture, and sale of pharmaceuticals and medical devices; and provision of human studies (functionality and safety evaluations), basic research and animal studies, food composition analysis, research on functional substances, and other research and analysis services, as well as consulting in support of functional food development and other activities. In addition, it engages in trading, investment, and other businesses; shared services; rental and sale of advanced medical and other devices; and sale of clinical trial and other types of life and non-life insurance. The company serves pharmaceutical companies, medical device manufacturers, pharmaceutical development ventures, medical institutions, and universities and research institution in Japan and Asia. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan. As of July 8, 2021, EPS Holdings, Inc. operates as a subsidiary of Y&G Limited.",Tokyo,81 3 5684 7873,Japan,http://www.eps-holdings.co.jp,86400,Kagurazaka AK Building,Diagnostics & Research,6th Floor 1-8 Tsukudo-cho Shinjuku-ku
t-2,EPLYF,37575000000.0,44192200,,,1707000000,2902000000,1004000000,3963000000,5413000000,1450000000,1450000000,,-4000000,,,,584000000,16618000000,15168000000,11205000000,257000000,,1123000000,1004000000,1439000000.0,13373000000.0,20449000000.0,44701000000.0,10946000000.0,68052000000.0,3888000000.0,3960000000.0,29570000000.0,2963000000.0,5687000000.0,-2130000000.0,2000000.0,19537000000.0,17284000000.0,159000000.0,672000000.0,7311000000.0,43992000000.0,9621000000.0,1479000000.0,15687000000.0,202000000.0,3329000000.0,959000000.0,,0,26708000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,16.3,1629395054,0.0,16.3,16.3,16.3,55,16.3,finmb_13104144,Other OTC,"EPS Holdings, Inc.",JPY,15,0,7.1849995,0.78826106,9.115 - 16.3,0.0,0.0,9.115,16.3,20.0,29.744526,1.2269939,REGULAR,us_market,EPS HOLDINGS INC,0,False,False,2,0.0,16.3 - 16.3,0.548,1050.582,16.083055,0.21694374,0.013488963,13.085471,3.214528,0.24565627,766357504,0.015515208,15,America/New_York,EDT,-14400000,0.79,,,16.3,9.11,16.08,13.09,15,,44.19M,,5.73M,83.23%,13.01%,,,,,,0.19,1.16%,20.00,122.70%,,32.64%,,"Sep 28, 2021",100:1,"Mar 26, 2014","Sep 29, 2020","Jun 29, 2021",4.27%,9.28%,5.68%,6.37%,71.74B,1623.13,22.40%,20.63B,9.04B,3.06B,0.55,230.60%,22.97B,519.79,10.9B,22.14,1.92,1050.58,,,Value,162-0821,Healthcare,6716,"EPS Holdings, Inc., through its subsidiaries, provides outsourced solutions to customers in the healthcare industry. It provides contract research organization (CRO) services and management of CRO segment activities; site management organization services; contract MR services, DI, and other call center services related BPO services, as well as medical device support services; contract sales solutions, including recruitment, training, and development of MRs (permanent, contract staffing, and temp to-perm), as well as medical communications programs and training; and promotion and BPO services for healthcare companies. The company also engages in clinical research related business; provision of IT services for pharmaceutical and medical settings; the import and export of products for non-clinical research, and provision of distribution services; research and development, manufacture, and sale of pharmaceuticals and medical devices; and provision of human studies (functionality and safety evaluations), basic research and animal studies, food composition analysis, research on functional substances, and other research and analysis services, as well as consulting in support of functional food development and other activities. In addition, it engages in trading, investment, and other businesses; shared services; rental and sale of advanced medical and other devices; and sale of clinical trial and other types of life and non-life insurance. The company serves pharmaceutical companies, medical device manufacturers, pharmaceutical development ventures, medical institutions, and universities and research institution in Japan and Asia. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan. As of July 8, 2021, EPS Holdings, Inc. operates as a subsidiary of Y&G Limited.",Tokyo,81 3 5684 7873,Japan,http://www.eps-holdings.co.jp,86400,Kagurazaka AK Building,Diagnostics & Research,6th Floor 1-8 Tsukudo-cho Shinjuku-ku
t-3,EPLYF,36683000000.0,44192200,,,735000000,2833000000,-82000000,4305000000,5684000000,1379000000,1379000000,,-5000000,,,,911000000,18208000000,16829000000,12524000000,-644000000,,-176000000,-82000000,1438000000.0,13382000000.0,23520000000.0,44105000000.0,12238000000.0,70458000000.0,3888000000.0,3496000000.0,29007000000.0,3097000000.0,5984000000.0,-2172000000.0,2808000000.0,22127000000.0,20219000000.0,209000000.0,630000000.0,7244000000.0,45909000000.0,7075000000.0,1378000000.0,16154000000.0,204000000.0,2754000000.0,753000000.0,2799000000.0,0,25690000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,16.3,1629395054,0.0,16.3,16.3,16.3,55,16.3,finmb_13104144,Other OTC,"EPS Holdings, Inc.",JPY,15,0,7.1849995,0.78826106,9.115 - 16.3,0.0,0.0,9.115,16.3,20.0,29.744526,1.2269939,REGULAR,us_market,EPS HOLDINGS INC,0,False,False,2,0.0,16.3 - 16.3,0.548,1050.582,16.083055,0.21694374,0.013488963,13.085471,3.214528,0.24565627,766357504,0.015515208,15,America/New_York,EDT,-14400000,0.79,,,16.3,9.11,16.08,13.09,15,,44.19M,,5.73M,83.23%,13.01%,,,,,,0.19,1.16%,20.00,122.70%,,32.64%,,"Sep 28, 2021",100:1,"Mar 26, 2014","Sep 29, 2020","Jun 29, 2021",4.27%,9.28%,5.68%,6.37%,71.74B,1623.13,22.40%,20.63B,9.04B,3.06B,0.55,230.60%,22.97B,519.79,10.9B,22.14,1.92,1050.58,,,Value,162-0821,Healthcare,6716,"EPS Holdings, Inc., through its subsidiaries, provides outsourced solutions to customers in the healthcare industry. It provides contract research organization (CRO) services and management of CRO segment activities; site management organization services; contract MR services, DI, and other call center services related BPO services, as well as medical device support services; contract sales solutions, including recruitment, training, and development of MRs (permanent, contract staffing, and temp to-perm), as well as medical communications programs and training; and promotion and BPO services for healthcare companies. The company also engages in clinical research related business; provision of IT services for pharmaceutical and medical settings; the import and export of products for non-clinical research, and provision of distribution services; research and development, manufacture, and sale of pharmaceuticals and medical devices; and provision of human studies (functionality and safety evaluations), basic research and animal studies, food composition analysis, research on functional substances, and other research and analysis services, as well as consulting in support of functional food development and other activities. In addition, it engages in trading, investment, and other businesses; shared services; rental and sale of advanced medical and other devices; and sale of clinical trial and other types of life and non-life insurance. The company serves pharmaceutical companies, medical device manufacturers, pharmaceutical development ventures, medical institutions, and universities and research institution in Japan and Asia. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan. As of July 8, 2021, EPS Holdings, Inc. operates as a subsidiary of Y&G Limited.",Tokyo,81 3 5684 7873,Japan,http://www.eps-holdings.co.jp,86400,Kagurazaka AK Building,Diagnostics & Research,6th Floor 1-8 Tsukudo-cho Shinjuku-ku
